Additionally, I want to address the practice of conducting weekly urinary drug screens. While monitoring is essential for patient safety and progress, frequent drug screenings can inadvertently lead to feelings of shame and inconvenience. Such practices may create barriers for patients, making them feel stigmatized rather than supported in their recovery efforts.

By prioritizing telehealth services and re-evaluating the frequency of drug screenings, we can foster a more compassionate and effective approach to MAT programs, ultimately empowering patients on their paths to recovery.